| Website | intersouth.com |
| Phone | 919.493.6640 |
| Employees |
Intersouth Partners is one of the most active and experienced venture funds in the Southeast, having invested in more than 90 private companies over the last two decades. Founded in 1985, Intersouth manages $780 million in seven venture capital limited partnerships, making it the largest venture capital fund in North Carolina and one of the largest in the Southeast.
| Company | Date | Round | Size | Participants |
| 480 Biomedical | 2/12 | Series A | $15M | 3 |
| CSA Medical | 12/11 | Series B | $20.5M | 4 |
| simplifyMD | 11/11 | Series A | $4.5M | 1 |
| Arsenal Vascular | 10/11 | Unattributed | $3M | 3 |
| Adaptivity | 9/11 | Unattributed | $6M | 3 |
| 6fusion | 8/11 | Series B | $7M | 2 |
| Semprius | 6/11 | Series C | $20M | 6 |
| PeopleMatter | 5/11 | Series B | $7.2M | 4 |
| Advanced Animal Diagnostics | 3/11 | Series B | $11M | 2 |
| Locaid | 2/11 | Series C | $13M | 2 |
| CallMiner | 10/10 | Unattributed | $7M | 3 |
| Adaptivity | 10/10 | Series A | $7.2M | 2 |
| CallMiner | 9/10 | Series C | $4M | 3 |
| 6fusion | 8/10 | Series A | $3M | 1 |
| Arsenal Vascular | 5/10 | Unattributed | $10M | 3 |
| Overture Networks | 4/10 | Unattributed | $17.2M | 7 |
| Arsenal Vascular | 3/10 | Debt | $1M | 3 |
| PeopleMatter | 2/10 | Unattributed | $7.2M | 2 |
| ABT Molecular Imaging | 1/10 | Series A | $9M | 1 |
| TransEnterix | 1/10 | Series B | $55M | 6 |
| MicroCHIPS | 1/10 | Unattributed | $16.5M | 9 |
| Calibra Medical | 11/09 | Unattributed | $1.4M | 5 |
| Zenph Sound Innovations | 11/09 | Series A | $10.7M | 2 |
| Alimera Sciences | 10/09 | Series C | $5M | 5 |
| Viamet Pharmaceuticals | 7/09 | Series B | $18M | 6 |
| Semprius | 6/09 | Series B | $6.4M | 5 |
| Applied Genetics Technologies Corporation | 6/09 | Series C | $11.8M | 3 |
| Cempra | 6/09 | Series C | $46M | 6 |
| Proteon Therapeutics | 5/09 | Series B | $50M | 8 |
| Bright View Technologies | 4/09 | Series C | $4M | 4 |
| Biolex Therapeutics | 10/08 | Series D | $60M | 12 |
| Clarabridge | 8/08 | Series C | $12M | 4 |
| Athenix | 7/08 | Series D | $10M | 3 |
| siXis | 6/08 | Series A | $5M | 2 |
| Aldagen | 4/08 | Series D | $18.4M | 4 |
| Mixx | 2/08 | Series B | $2M | 1 |
| Zenoss | 1/08 | Series B | $11M | 4 |
| Proteon Therapeutics | 9/07 | Series A | $12M | 4 |
| Aldagen | 9/07 | Series C | $9M | 4 |
| Mixx | 9/07 | Series A | $1.5M | 1 |
| Semprius | 7/07 | Series A | $4.1M | 3 |
| Argolyn Bioscience | 6/07 | Series A | $15.8M | 3 |
| Viamet Pharmaceuticals | 6/07 | Series A | $4M | 2 |
| Biolex Therapeutics | 5/07 | Series C | $30M | 9 |
| FlatBurger | 5/07 | Series A | $5M | 2 |
| Defywire | 3/07 | Unattributed | $7M | 3 |
| 6th Sense Analytics | 1/07 | Series A | $5M | 2 |
| Clarabridge | 1/07 | Series B | $7.2M | 2 |
| Ziptronix | 1/07 | Series D | $2.8M | 5 |
| Jacket Micro Devices | 10/06 | Unattributed | $12M | 4 |
| Zenoss | 8/06 | Series A | $4.8M | 4 |
| COVEGA | 8/06 | Unattributed | $10M | 4 |
| CallMiner | 7/06 | Series B | $10M | 4 |
| Nitronex | 6/06 | Unattributed | $21.8M | 6 |
| Overture Networks | 6/06 | Series C | $7.5M | 6 |
| KAI Pharmaceuticals | 5/06 | Series B | $35M | 8 |
| FlatBurger | 3/06 | Seed | $1.75M | 2 |
| Athenix | 1/06 | Series C | $13M | 6 |
| HexaTech | 11/05 | Series A | $8.9M | 4 |
| Alimera Sciences | 11/05 | Series B | $31.8M | 5 |
| Locaid | 11/05 | Series A | $5M | 2 |
| 6th Sense Analytics | 11/05 | Unattributed | $1.7M | 1 |
| TapRoot Systems | 9/05 | Series B | $6.5M | 3 |
| Biolex Therapeutics | 9/05 | Series B | $36M | 6 |
| Ziptronix | 8/05 | Series C | $7.2M | 6 |
| Defywire | 4/05 | Series B | $3.6M | 3 |
| Digital Safety Technologies | 4/05 | Unattributed | $41.1M | 5 |
| Invistics | 1/05 | Series B | $5M | 3 |
| Athenix | 1/04 | Series B | $12.5M | 5 |
| Applied Genetics Technologies Corporation | 11/03 | Series B | $27M | 4 |
| Athenix | 9/01 | Series A | $8M | 3 |
| Sentillion | 9/01 | Series C | $18M | 7 |
| Sentillion | 4/00 | Series B | $8.75M | 5 |
| Sentillion | 3/99 | Series A | $2.7M | 3 |
